|
Market Cap (18-May) $26,586,560 (621st) |
Close (30-Jun) $0.58 |
Volume (30-Jun) 102,948 |
Shortsold (3-Jul) 1,500 (0.00%) (620th) |
|
52w High $0.315 |
52w Low $0.081 |
P/E 128.21 |
EPS -0.06 |
NXS released this announcement to the ASX on 19 May 2022, 11:39. The announcement is marked as price sensitive, and is 2 page(s) in length and 87.14kb in size.
You can view all announcements from NXS and see how they appear on a price chart on the announcements page.
At the date of this announcement, NXS was 0.002% short sold according to ASIC data. It was ranked the 665th most shorted stock on the ASX. It is now ranked as the 620th most shorted stock on the ASX with 0.001% of total shares short sold as of the latest reported data (03 July 2024).
| Other Recent Announcements from NXS | |
|---|---|
| Director Retirement | 30 June 2023, 9:09 |
| Market Update | 29 June 2023, 9:44 |
| Appointment of new Managing Director and CEO | 16 June 2023, 8:25 |
| Oraderm Pharmaceuticals appointed as BlastX distributor | 19 May 2022, 11:39 |
| Investor Presentation - Q1 2022 | 28 April 2022, 8:31 |
| Appendix 4C - 31 March 2022 | 28 April 2022, 8:20 |
| Quarterly Activity Report - 31 March 2022 | 28 April 2022, 8:20 |
You must be logged in to post a reply.
Next Science 